Lv2
150 积分 2024-11-05 加入
Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways
1个月前
已完结
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases
1个月前
已完结
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
6个月前
已完结
Strategic Synthesis and Antimycobacterial Evaluation of Coumarin- and Quinoline-Substituted s-Triazine Derivatives via Palladium-Catalyzed Suzuki Coupling
9个月前
已完结
皖公网安备34019202002308
